Jefferies Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jefferies Financial Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.7M	Buy	1,800,113 +1,049,292	+140%	+$33.4M	0.5%	29
2026 Q1	$19.8M	Buy	+750,821	New	+$22M	0.14%	120
2025 Q1	–	Sell	-8,615	Closed	-$203K	–	1602
2024 Q4	$203K	Sell	8,615 -27	-0.3%	-$664	﹤0.01%	1379
2024 Q3	$221K	Buy	+8,642	New	+$220K	﹤0.01%	1203
2023 Q4	–	Sell	-70,308	Closed	-$1.96M	–	1683
2023 Q3	$1.96M	Buy	+70,308	New	+$2.3M	0.02%	631
2023 Q1	–	Sell	-9,055	Closed	-$256K	–	1613
2022 Q4	$256K	Buy	+9,055	New	+$287K	﹤0.01%	1232

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jefferies Financial Group's ARKG Position: Q2 2026 in Review

Jefferies Financial Group increased its ARK Genomic Revolution ETF (ARKG) stake by 140% in Q2 2026, buying an estimated $33.4M and bringing the position to 1,800,113 shares worth $75.7M. The position accounts for 0.5% of the portfolio, ranked #29.

Jefferies Financial Group first reported a position in ARKG in Q4 2022 and has held it in 6 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Jefferies Financial Group held 1,800,113 shares of ARK Genomic Revolution ETF worth $75.7M as of Q2 2026.
Jefferies Financial Group bought 1,049,292 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $33.4M.
ARK Genomic Revolution ETF made up 0.5% of Jefferies Financial Group's portfolio in Q2 2026, its #29 holding.
Jefferies Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 6 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.